For citations:
Loukianov M.M., Martsevich S.Yu., Andrenko E.Yu., Yakushin S.S., Vorobiev A.N., Pereverzeva K.G., Zagrebelny A.V., Okshina Е.Yu., Yakusevich V.V., Yakusevich V.V., Pozdnyakova E.M., Gomova T.A., Fedotova E.E., Valiakhmetov M.M., Mikhin V.P., Maslennikova Yu.V., Belova E.N., Klyashtorny V.G., Kudryashov E.V., Makoveeva A.N., Tatsii J.E., Boytsov S.A., Drapkina O.M. Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries). Rational Pharmacotherapy in Cardiology. 2021;17(5):702-711. https://doi.org/10.20996/1819-6446-2021-10-03
Email this article 